Page last updated: 2024-10-23

azathioprine and Pars Planitis

azathioprine has been researched along with Pars Planitis in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Pars Planitis: Form of granulomatous uveitis occurring in the region of the pars plana. This disorder is a common condition with no detectable focal pathology. It causes fibrovascular proliferation at the inferior ora serrata.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Serna-Ojeda, JC1
Pedroza-Seres, M1

Other Studies

1 other study available for azathioprine and Pars Planitis

ArticleYear
Treatment with immunosuppressive therapy in patients with pars planitis: experience of a reference centre in Mexico.
    The British journal of ophthalmology, 2014, Volume: 98, Issue:11

    Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Hu

2014